Provided by Tiger Trade Technology Pte. Ltd.

Klotho Neurosciences, Inc.

0.2402
+0.01958.84%
Post-market: 0.2300-0.0102-4.25%19:54 EST
Volume:605.21K
Turnover:141.13K
Market Cap:17.66M
PE:-0.79
High:0.2427
Open:0.2309
Low:0.2229
Close:0.2207
52wk High:3.91
52wk Low:0.1135
Shares:73.54M
Float Shares:56.78M
Volume Ratio:0.82
T/O Rate:1.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3046
EPS(LYR):-0.3195
ROE:-198.28%
ROA:-71.63%
PB:1.78
PE(LYR):-0.75

Loading ...

Company Profile

Company Name:
Klotho Neurosciences, Inc.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
3
Office Location:
13576 Walnut Street,Suite A,Omaha,Nebraska,United States
Zip Code:
68144
Fax:
- -
Introduction:
Klotho Neurosciences, Inc., a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors. The company has a strategic partnership with Japan's Okinawa Research Center for the research and development of Klotho gene therapy in enhancing longevity and reducing age-related diseases. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha, Nebraska.

Directors

Name
Position
Joseph Sinkule
Chairman of the Board and Chief Executive Officer
Jon W. Mcgarity
Independent Director
Riad El Dada
Independent Director
Samuel M. Zentman
Independent Director
Shalom Z. Hirschman
Independent Director

Shareholders

Name
Position
Joseph Sinkule
Chairman of the Board and Chief Executive Officer
Peter Moriarty
Chief Operating Officer
Jeffrey Brian LeBlanc
Chief Financial Officer and Principal Accounting Officer